US Stock MarketDetailed Quotes

RPRX Royalty Pharma

Watchlist
  • 32.360
  • -0.100-0.31%
Close Feb 14 16:00 ET
  • 32.008
  • -0.352-1.09%
Post 17:16 ET
14.02BMarket Cap16.94P/E (TTM)

Royalty Pharma Key Stats

Royalty Pharma Q4 2024 Earnings Date

Currency:USDFeb 11, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
743.60M
593.64M
-149.96M
Miss Est.
+24.77%
-0.41%
-20.17%
EPS
0.25
0.35
+0.10
Beat Est.
-77.27%
-67.90%
+41.24%
Strong Buy

Feb 12, 2025

Royalty Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 654.000M--
--2025/Q1-- / 806.000M--
Feb 11, 20252024/Q4594.000M / 743.604M--
Nov 6, 20242024/Q3565.000M / 731.832M--
Aug 8, 20242024/Q2537.000M / 645.290M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 654.000M--
--2025/Q1-- / 806.000M--
Feb 11, 20252024/Q4594.000M / 743.604M--
Nov 6, 20242024/Q3565.000M / 731.832M--
Aug 8, 20242024/Q2537.000M / 645.290M--

Unlock Free Earnings Estimates

Royalty Pharma Earnings Reports

Read more

Trending Stocks

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More